Coyle A J, Ackerman S J, Burch R, Proud D, Irvin C G
Department of Medicine, University of Colorado Health Science Center, Denver 80206, USA.
J Clin Invest. 1995 Apr;95(4):1735-40. doi: 10.1172/JCI117850.
In the current series of experiments we investigated the role of bradykinin in airway hyperresponsiveness induced by human eosinophil-granule major basic protein (MBP). Bronchoalveolar lavage was performed after intratracheal instillation of MBP or poly-L-lysine in anesthetized, intubated rats, and levels of immunoreactive kinins and kallikrein-like activity were determined. Both MBP and poly-L-lysine induced a three- and eightfold increase in levels of kallikrein-like activity and i-kinins, respectively. To determine whether kinin production is required for the development of airway hyperresponsiveness induced by cationic proteins, dose-response curves to methacholine were constructed before and 1 h after intratracheal instillation of either MBP or poly-L-lysine (100 micrograms). MBP and poly-L-lysine induced an increase in airway responsiveness, which was inhibited by pretreatment with a selective BK-2 receptor antagonist, NPC 17713 (250 micrograms/ml). Our results demonstrate that MBP and poly-L-lysine activate kallikrein and stimulate the generation of i-kinins in vivo, an effect that may be related to the cationic charge of these proteins. Furthermore, the ability of these proteins to increase airway responsiveness appears to be dependent on the generation of i-kinins.
在当前这一系列实验中,我们研究了缓激肽在人嗜酸性粒细胞颗粒主要碱性蛋白(MBP)诱导的气道高反应性中的作用。在麻醉、插管的大鼠气管内滴注MBP或聚-L-赖氨酸后进行支气管肺泡灌洗,并测定免疫反应性激肽和激肽释放酶样活性水平。MBP和聚-L-赖氨酸分别使激肽释放酶样活性水平和i-激肽水平增加了三倍和八倍。为了确定阳离子蛋白诱导的气道高反应性发展是否需要激肽产生,在气管内滴注MBP或聚-L-赖氨酸(100微克)之前和之后1小时构建对乙酰甲胆碱的剂量反应曲线。MBP和聚-L-赖氨酸诱导气道反应性增加,这被选择性BK-2受体拮抗剂NPC 17713(250微克/毫升)预处理所抑制。我们的结果表明,MBP和聚-L-赖氨酸在体内激活激肽释放酶并刺激i-激肽的产生,这种效应可能与这些蛋白质的阳离子电荷有关。此外,这些蛋白质增加气道反应性的能力似乎依赖于i-激肽的产生。